FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2597407310> ?p ?o ?g. }

• W2597407310 endingPage "3178" @default.
• W2597407310 startingPage "3172" @default.
• W2597407310 abstract "The aim of the present study was to investigate the protective effect of tacrolimus on early podocyte damage in rats with diabetic nephropathy (DN). A total of 38 normal male Sprague‑Dawley rats were randomly divided into four groups: Normal control group (group N; n=8), DN group (n=10), tacrolimus (FK506) treatment group (group F; n=10), benazepril (Lotensin) treatment group (group L; n=10). The rats in groups DN, F and L were administered with streptozotocin (STZ; 60 mg/kg) by intraperitoneal injection to establish the diabetic rat model. After 4 weeks, the diabetic rat model was established, and rats in the different groups were administered intragrastically with the respective drugs. Blood glucose (BS), body weight (BW) and 24‑h urine protein were detected every 4 weeks, serum creatinine (SCr), blood urea nitrogen (BUN) and kidney weight/body weight (KW/BW) were measured at the end of the 8 weeks of drug treatment. Renal pathological changes were observed under a light microscope and electron microscope. Expression of nephrin, which is a podocyte‑specific marker, was detected using western blot analysis. The results showed that the levels of SCr, BUN, KW/BW and 24‑h urine protein in groups D, F and L were significantly higher, compared with those in group N (P<0.05). No significant differences were found between groups F and L for the above indicators, with the exception of BS. However, all indices were significantly lower, compared with those in group DN (P<0.05). Renal pathological expression was normal in group N under light microscopy. There were significant increases in the glomerular volume, proliferative mesangial cells, width of the mesangial area and thickness of the basement membrane in group DN, however, all the above pathological characteristics were reduced in groups F and L, compared with group DN (P<0.05). No significant difference was found between groups F and L. A widened glomerular basement membrane, and disorder, widening and fusion of podocyte processes were observed under the electron microscope in group DN, however, these were reduced in groups F and L, compared with group DN (P<0.05). The results of the western blot analysis showed that the expression of nephrin decreased by 60.1% in group DN, compared with group N, and significant recovery in the expression of nephrin was observed in groups F and L (P<0.05). Tacrolimus reduced urinary protein and slowed the progression of DN, partially by recovering the protein expression of nephrin in the renal tissue of diabetic rats, and maintaining the integrity of the structure and function of podocytes." @default.
• W2597407310 created "2017-04-07" @default.
• W2597407310 creator A5028918977 @default.
• W2597407310 creator A5040179399 @default.
• W2597407310 creator A5066344991 @default.
• W2597407310 creator A5067011111 @default.
• W2597407310 creator A5081578444 @default.
• W2597407310 creator A5088972223 @default.
• W2597407310 date "2017-03-22" @default.
• W2597407310 modified "2023-10-01" @default.
• W2597407310 title "Protective effects of tacrolimus on podocytes in early diabetic nephropathy in rats" @default.
• W2597407310 cites W1504829508 @default.
• W2597407310 cites W1538950662 @default.
• W2597407310 cites W1865290790 @default.
• W2597407310 cites W1887837461 @default.
• W2597407310 cites W1949127213 @default.
• W2597407310 cites W1968391914 @default.
• W2597407310 cites W2022535599 @default.
• W2597407310 cites W2023247385 @default.
• W2597407310 cites W2023779145 @default.
• W2597407310 cites W2025176077 @default.
• W2597407310 cites W2032045715 @default.
• W2597407310 cites W2034355001 @default.
• W2597407310 cites W2062595339 @default.
• W2597407310 cites W2066523658 @default.
• W2597407310 cites W2068164245 @default.
• W2597407310 cites W2069890348 @default.
• W2597407310 cites W2073711398 @default.
• W2597407310 cites W2086300204 @default.
• W2597407310 cites W2086672882 @default.
• W2597407310 cites W2101416204 @default.
• W2597407310 cites W2102945856 @default.
• W2597407310 cites W2110052102 @default.
• W2597407310 cites W2110684317 @default.
• W2597407310 cites W2112549609 @default.
• W2597407310 cites W2124847465 @default.
• W2597407310 cites W2130920243 @default.
• W2597407310 cites W2146159635 @default.
• W2597407310 cites W2151308138 @default.
• W2597407310 cites W2162304120 @default.
• W2597407310 doi "https://doi.org/10.3892/mmr.2017.6354" @default.
• W2597407310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28339051" @default.
• W2597407310 hasPublicationYear "2017" @default.
• W2597407310 type Work @default.
• W2597407310 sameAs 2597407310 @default.
• W2597407310 citedByCount "7" @default.
• W2597407310 countsByYear W25974073102018 @default.
• W2597407310 countsByYear W25974073102020 @default.
• W2597407310 countsByYear W25974073102021 @default.
• W2597407310 countsByYear W25974073102023 @default.
• W2597407310 crossrefType "journal-article" @default.
• W2597407310 hasAuthorship W2597407310A5028918977 @default.
• W2597407310 hasAuthorship W2597407310A5040179399 @default.
• W2597407310 hasAuthorship W2597407310A5066344991 @default.
• W2597407310 hasAuthorship W2597407310A5067011111 @default.
• W2597407310 hasAuthorship W2597407310A5081578444 @default.
• W2597407310 hasAuthorship W2597407310A5088972223 @default.
• W2597407310 hasBestOaLocation W25974073101 @default.
• W2597407310 hasConcept C126322002 @default.
• W2597407310 hasConcept C134018914 @default.
• W2597407310 hasConcept C185592680 @default.
• W2597407310 hasConcept C2777146197 @default.
• W2597407310 hasConcept C2777363265 @default.
• W2597407310 hasConcept C2778176769 @default.
• W2597407310 hasConcept C2779280383 @default.
• W2597407310 hasConcept C2779561371 @default.
• W2597407310 hasConcept C2779922275 @default.
• W2597407310 hasConcept C2780026642 @default.
• W2597407310 hasConcept C2780091579 @default.
• W2597407310 hasConcept C2780159080 @default.
• W2597407310 hasConcept C2780306776 @default.
• W2597407310 hasConcept C2780819817 @default.
• W2597407310 hasConcept C2909675724 @default.
• W2597407310 hasConcept C2911091166 @default.
• W2597407310 hasConcept C555293320 @default.
• W2597407310 hasConcept C71924100 @default.
• W2597407310 hasConcept C84393581 @default.
• W2597407310 hasConceptScore W2597407310C126322002 @default.
• W2597407310 hasConceptScore W2597407310C134018914 @default.
• W2597407310 hasConceptScore W2597407310C185592680 @default.
• W2597407310 hasConceptScore W2597407310C2777146197 @default.
• W2597407310 hasConceptScore W2597407310C2777363265 @default.
• W2597407310 hasConceptScore W2597407310C2778176769 @default.
• W2597407310 hasConceptScore W2597407310C2779280383 @default.
• W2597407310 hasConceptScore W2597407310C2779561371 @default.
• W2597407310 hasConceptScore W2597407310C2779922275 @default.
• W2597407310 hasConceptScore W2597407310C2780026642 @default.
• W2597407310 hasConceptScore W2597407310C2780091579 @default.
• W2597407310 hasConceptScore W2597407310C2780159080 @default.
• W2597407310 hasConceptScore W2597407310C2780306776 @default.
• W2597407310 hasConceptScore W2597407310C2780819817 @default.
• W2597407310 hasConceptScore W2597407310C2909675724 @default.
• W2597407310 hasConceptScore W2597407310C2911091166 @default.
• W2597407310 hasConceptScore W2597407310C555293320 @default.
• W2597407310 hasConceptScore W2597407310C71924100 @default.
• W2597407310 hasConceptScore W2597407310C84393581 @default.
• W2597407310 hasIssue "5" @default.
• W2597407310 hasLocation W25974073101 @default.

• next